Review

Nature 464, 217-223 (11 March 2010) | doi:10.1038/nature08757

Targeting early infection to prevent HIV-1 mucosal transmission

Ashley T. Haase1

Measures to prevent sexual mucosal transmission of human immunodeficiency virus (HIV)-1 are urgently needed to curb the growth of the acquired immunodeficiency syndrome (AIDS) pandemic and ultimately bring it to an end. Studies in animal models and acute HIV-1 infection reviewed here reveal potential viral vulnerabilities at the mucosal portal of entry in the earliest stages of infection that might be most effectively targeted by vaccines and microbicides, thereby preventing acquisition and averting systemic infection, CD4 T-cell depletion and pathologies that otherwise rapidly ensue.

  1. Department of Microbiology, University of Minnesota, Minnesota 55455, USA

Correspondence to: Ashley T. Haase1 Correspondence should be addressed to the author (Email: haase001@umn.edu).

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Progress towards a vaccine to prevent sexual transmission of HIV

Nature Medicine News and Views (01 Jul 1996)

Breaching barriers

Nature Medicine News and Views (01 Oct 1996)

See all 4 matches for News And Views